EDSA Edesa Biotech, Inc.

Fundamentals / CIK 0001540159 / USD

Edesa Biotech, Inc. reported $12.72M in total assets and a net loss of $14.10M through September 30, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open EDSA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2015 to 2025), reported in USD.

$3.11M$1.55M$0-$16.52MFY 2015 Revenue: $759KFY 2015 Net Income: -$2.84M2015FY 2016 Revenue: $1.27MFY 2016 Net Income: -$5.03M2016FY 2017 Revenue: $228KFY 2017 Net Income: -$5.03M2017FY 2018 Revenue: $212KFY 2018 Net Income: -$5.04M2018FY 2020 Revenue: $329KFY 2020 Net Income: -$6.36M2020FY 2021 Revenue: $0FY 2021 Net Income: -$13.34M2021FY 2022 Net Income: -$17.55M2022FY 2023 Net Income: -$8.37M2023FY 2024 Net Income: -$6.17M2024FY 2025 Net Income: -$7.19M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Revenue -- -- -- -- $0 $329K $212K $228K $1.27M $759K
Cost of Revenue -- -- -- -- $0 $18K $133K $250K $819K $581K
Gross Profit -- -- -- -- $0 $311K $79K -$22K $453K $178K
Research & Development $3.67M $2.88M $4.79M $13.34M $17.95M $3.33M $2.09M $1.97M $1.73M $1.03M
Total Operating Expenses -- -- -- -- -- $6.73M $5.29M $5.45M $6.18M $5.10M
Operating Income -$7.91M -$7.01M -$9.22M -$18.37M -$23.68M -$6.40M -$5.08M -$5.22M -$4.91M -$4.34M
EBITDA -$7.79M -$6.83M -$9.04M -$18.25M -$23.56M -$6.34M -$4.89M -$5.05M -$4.76M -$4.18M
Interest Income $2.6K $153K $290K $64K $11K $38K $75K $33K $25K $55K
Income Before Tax -$7.18M -$6.17M -$8.37M -$17.55M -$13.34M -- -$5.04M -$5.03M -$5.02M -$2.81M
Income Tax Expense $800 $800 $800 $800 $800 $800 $800 $800 $7.2K $37K
Net Income -$7.19M -$6.17M -$8.37M -$17.55M -$13.34M -$6.36M -$5.04M -$5.03M -$5.03M -$2.84M
Basic EPS -$1.27 -$1.93 -$2.93 -- -$1.10 -$0.74 -$1.76 -$3.44 -$0.57 -$0.36
Diluted EPS -- -- -- -- -$1.10 -$0.74 -$1.76 -$3.44 -$0.57 -$0.36
Basic Shares Outstanding 5.7M 3.2M 2.9M -- 12.1M 8.6M 2.9M 1.5M 8.8M 8.0M
Diluted Shares Outstanding -- -- -- -- 12.1M 8.6M 2.9M 1.5M 8.8M 8.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Research & Development $3.96M $2.77M $1.12M $1.23M $939K $484K $1.02M $104K
Operating Income -$5.52M -$4.30M -$2.34M -$2.47M -$1.90M -$1.64M -$1.90M -$1.00M
EBITDA -$5.49M -$4.27M -$2.32M -$2.44M -$1.88M -$1.61M -$1.86M -$960K
Interest Income $275 $639 $47 $55 $572 $265 $1.7K $16K
Income Before Tax -$5.41M -$4.22M -- -- -$1.75M -$1.59M -- --
Income Tax Expense $0 $800 -- -- $0 $800 -- --
Net Income -$5.41M -$4.22M -$2.25M -$2.23M -$1.75M -$1.59M -$1.62M -$962K
Basic EPS -$0.60 -$0.49 -$0.28 -- -$0.25 -$0.30 -$0.48 --
Basic Shares Outstanding 9.0M 8.5M 8.0M -- 7.0M 5.3M 3.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Cash & Cash Equivalents $10.80M $1.00M $5.40M $7.09M $7.84M $7.21M $5.03M $3.73M $4.57M $7.42M
Short-Term Investments -- -- -- -- -- -- $0 $6.08M $1.99M $3.99M
Cash & Short-Term Investments $10.80M $1.00M $5.40M $7.09M $7.84M $7.21M $5.03M $9.81M $6.57M $11.41M
Accounts Receivable, Net -- -- -- -- $3.30M $87K $217K $41K $1.3K $86K
Inventory -- -- -- -- -- -- -- $224K $68K $249K
Total Current Assets $11.51M $1.68M $6.44M $9.09M $12.09M $8.10M $5.64M $10.66M $6.76M $12.10M
Property, Plant & Equipment, Net -- $0 $8.7K $13K $15K $15K $73K $1.06M $880K $756K
Intangible Assets $1.98M $2.08M $2.18M $2.28M $2.38M $2.48M $0 -- -- --
Total Non-Current Assets $2.02M $2.14M $2.45M $2.48M $2.49M $2.66M $73K $1.12M $962K $838K
Total Assets $13.53M $3.81M $8.89M $11.58M $14.58M $10.76M $5.72M $11.78M $7.72M $12.94M
Deferred Revenue (Current) -- -- -- -- -- -- -- $0 -- $0
Total Current Liabilities $1.08M $1.83M $1.82M $2.14M $1.46M $1.53M $462K $493K $321K $624K
Total Non-Current Liabilities $0 $0 $20K $44K $68K $124K $0 $7.74M $0 $0
Total Liabilities $1.08M $1.83M $1.84M $2.18M $1.53M $1.65M $462K $8.23M $321K $624K
Total Debt (incl. Leases) -- $20K $94K $19K $99K $164K -- -- -- --
Common Stock $54.52M $47.24M $46.64M $42.47M $34.89M $18.50M $12.01M $56.65M $48.35M $47.28M
Retained Earnings -$65.91M -$58.59M -$52.42M -$44.04M -$26.50M -$13.13M -$6.73M -$50.43M -$45.39M -$40.36M
Accumulated Other Comp. Income -$166K -$243K -$215K -$214K -$205K -$287K -$342K -- -- --
Total Stockholders' Equity $12.45M $1.98M $7.05M $9.39M $13.06M $6.63M $5.26M $3.55M $7.40M $12.31M
Total Equity $12.45M $1.98M $7.05M $9.39M $13.06M $6.63M $5.26M $3.55M $7.40M $12.31M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Cash & Cash Equivalents $10.30M $10.00M $12.10M $10.80M $12.40M $13.90M $1.60M $1.00M
Cash & Short-Term Investments $10.30M $10.00M $12.10M $10.80M $12.40M $13.90M $1.60M $1.00M
Total Current Assets $10.78M $10.42M $12.72M $11.51M $12.76M $14.39M $2.07M $1.68M
Property, Plant & Equipment, Net -- -- -- -- -- -- -- $0
Intangible Assets $1.90M $1.93M $1.95M $1.98M $2.00M $2.03M $2.05M $2.08M
Total Non-Current Assets $1.94M $1.97M $1.99M $2.02M $2.04M $2.07M $2.09M $2.14M
Total Assets $12.72M $12.38M $14.71M $13.53M $14.80M $16.45M $4.16M $3.81M
Total Current Liabilities $3.91M $2.19M $756K $1.08M $673K $915K $1.90M $1.83M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $3.91M $2.19M $756K $1.08M $673K $915K $1.90M $1.83M
Total Debt (incl. Leases) -- -- -- -- -- -- -- $20K
Common Stock $62.42M $58.93M $57.90M $54.52M $54.27M $54.27M $47.56M $47.24M
Retained Earnings -$77.90M -$72.45M -$68.20M -$65.91M -$63.65M -$61.86M -$60.23M -$58.59M
Accumulated Other Comp. Income -$159K -$186K -$171K -$166K -$123K -$288K -$224K -$243K
Total Stockholders' Equity $8.81M $10.20M $13.95M $12.45M $14.13M $15.54M $2.26M $1.98M
Total Equity $8.81M $10.20M $13.95M $12.45M $14.13M $15.54M $2.26M $1.98M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Net Income -$7.19M -$6.17M $8.37M $17.55M $13.34M -$6.36M -$5.04M -$5.03M -$5.03M -$2.84M
Depreciation & Amortization $119K $186K $183K $118K $119K $58K $188K $179K $150K $160K
Stock-Based Compensation $730K $537K $1.25M $2.26M $3.20M $598K $154K $116K $259K $267K
Change in Receivables -- -- -- -$2.03M -$3.23M -$127K -$40K $85K $72K -$114K
Change in Inventory -- -- -- -- -- $0 -$156K $181K $308K -$522K
Operating Cash Flow -$7.32M -$4.89M -$6.64M -$12.28M -$13.66M -$4.99M -$4.62M -$4.70M -$4.51M -$4.41M
Capital Expenditure -- -- $0 -$5.7K -$6.1K -$4.9K -$383K -$303K -$402K -$275K
Free Cash Flow -- -- -$6.64M -$12.28M -$13.67M -$4.99M -$5.00M -$5.00M -$4.91M -$4.69M
Purchases of Investments -- -- -- -- -- -- -$9.08M -$5.01M -$12.00M -$14K
Investing Cash Flow -- -- $0 -$5.7K -$6.1K $19K -$4.47M $1.69M $557K $122K
Common Stock Issued $7.72M $729K $4.35M $11.96M $42K $4.36M $4.52M $0 $6.28M $0
Financing Cash Flow $17.03M $592K $4.83M $11.63M $14.17M $7.09M $8.77M $0 $7.31M $107K
Net Change in Cash $9.75M -$4.32M -$1.73M -$748K $626K $2.18M -$345K -$2.85M $3.46M -$4.81M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Net Income -$5.41M -$4.22M -$2.25M -$2.23M -$1.75M -$1.59M -$1.62M -$962K
Depreciation & Amortization $26K $26K $25K $26K $26K $25K $43K $44K
Stock-Based Compensation $547K $485K $400K $404K $177K $67K $81K $94K
Operating Cash Flow -$3.08M -$2.02M -$2.09M -$1.72M -$1.70M -$2.38M -$1.52M -$967K
Common Stock Issued $3.50M $0 $3.50M $221K $0 $6.87M $627K $0
Financing Cash Flow $3.45M -$9.0K $3.36M $186K $0 $14.77M $2.07M -$31K
Net Change in Cash $329K -$2.05M $1.26M -$1.57M -$1.53M $12.33M $526K -$1.00M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30 Sep 30
Gross Margin -- -- -- -- -- 94.6% 37.1% -9.5% 35.6% 23.4%
Operating Margin -- -- -- -- -- -1946.7% -2397.1% -2288.6% -386.0% -571.9%
Net Profit Margin -- -- -- -- -- -1935.3% -2378.6% -2203.7% -395.2% -374.7%
Return on Equity (ROE) -57.7% -311.4% -118.8% -186.9% -102.2% -96.0% -141.9% -68.0% -40.8% -35.5%
Return on Assets (ROA) -53.1% -161.8% -94.2% -151.6% -91.5% -59.1% -42.8% -65.2% -38.8% -27.4%
Current Ratio 10.67x 0.91x 3.53x 4.25x 8.29x 5.30x 21.60x 21.06x 19.40x 4.14x
Quick Ratio 10.01x 0.55x 2.96x 3.31x 7.64x 4.77x 21.14x 20.85x 19.00x 3.91x
Debt to Equity -- 0.01x 0.01x 0.00x 0.01x 0.02x -- -- -- --
Revenue Growth (YoY) -- -- -- -- -100.0% -- -7.2% -82.0% +67.6% +103.9%
Gross Profit Growth (YoY) -- -- -- -- -100.0% -- -- -104.8% +154.8% --
5Y Revenue / Share Growth -- -- -- -- -100.0% -59.9% -30.1% +2288.8% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Return on Equity (ROE) -160.0% -102.4% -56.0% -57.7% -41.9% -37.6% -269.8% -311.4%
Return on Assets (ROA) -110.9% -84.3% -53.1% -53.1% -40.0% -35.5% -146.7% -161.8%
Current Ratio 2.76x 4.76x 16.82x 10.67x 18.97x 15.73x 1.09x 0.91x
Quick Ratio 2.63x 4.57x 16.00x 10.01x 18.43x 15.20x 0.84x 0.55x
Debt to Equity -- -- -- -- -- -- -- 0.01x
Source: SEC EDGAR CompanyFacts (CIK 0001540159) · from August 31, 2012 Data through June 30, 2026 · synced Nov 21, 2026, 05:04 UTC · Open in terminal